RAMM Pharma

RAMM Pharma Buyback Yield

Buyback Yield of RAMM Pharma (RAMM.CN) as of Oct 16, 2026.

Buyback Yield

0.00

Last updated:

Buyback Yield of RAMM Pharma is 2025 0.00 . Buyback Yield of RAMM Pharma was 2024 0.00 . It decreases by % lower compared to the previous year.

The RAMM Pharma Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2018
0.00 CAD
Jan 1, 2019
0.00 CAD
Jan 1, 2020
27.92 CAD
Jan 1, 2021
5.18 CAD
Jan 1, 2022
12.35 CAD
Jan 1, 2023
9.75 CAD
Jan 1, 2024
0.00 CAD
Jan 1, 2025
0.00 CAD
The RAMM Pharma Buyback Yield history
YEARBuyback YieldYoY
0.00—
0.00-100.00%
9.75 %-21.02%
12.35 %+138.44%
5.18 %-81.45%
27.92 %—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp, listed under the ticker RAMM.CN with ISIN CA75150G1046, is a Canadian company headquartered in Toronto. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. The company completed its initial public offering on November 8, 2019. RAMM Pharma Corp focuses on cannabinoid pharmacology and the formulation of cannabis-based pharmaceuticals and related products. It also engages in the production, export, and commercialization of pet products, food, pharmaceutical specialties, household items, and cosmetics. The firm manages several brands, including NettaLife, which encompasses NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet. Its cosmetics line features products such as Cannabipiel Nite, Cannabipiel Body Lotion, Cannabipiel Hair Conditioner, Cannabipiel Liquid Soap, Cannabipiel Tite, Cannabipiel Cleaning Emulsion, Cannabipiel Shampoo, Cannabipiel Lite, and Cannbipiel Facial Tonic. Subsidiaries of the company include Canapar Corp., Medic Plast SA, Yurelan SA, Glediser SA, and RAMM Pharma Holdings Corp. The company's website is www.wearerammpharma.com. RAMM Pharma Corp is active in developing and distributing products related to cannabinoid-based pharmaceuticals and consumer goods in multiple categories. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

On Eulerpool you can find the complete historical development of Buyback Yield RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's RAMM Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RAMM Pharma

All Key Metrics — RAMM Pharma